Evommune, Inc.
€12
EUR
Last updated on --.
24h volume4.03K
24h highest12.2637 EUR
24h lowest12.0704 EUR
24h Price movement-0.94%
EVMN recent prices
24 Hours
-0.94%-€0.1134
30 days
+22.93%+€2.216
60 days
-8.11%-€1.049
90 days
-40.46%-€8.076
Key data
Previous close12.1219 EUR
Market cap440.24M EUR
Volume4.03K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.8213 EUR
Net income (FY)-66.13M EUR
Revenue (FY)11.17M EUR
Last report dateMay 7, 2026
About Evommune, Inc.
HeadquartersPALO ALTO
Employees (FY)48.00
Revenue per employee (FY)232.67K EUR
Net income per employee (FY)-1.38M EUR
Listed onNew York Stock Exchange
EVMN conversion tables
 |  |
|---|---|
| 0.5 EVMN | 6.004 EUR |
| 1 EVMN | 12 EUR |
| 5 EVMN | 60.04 EUR |
| 10 EVMN | 120.08 EUR |
| |
|---|---|
| 0.5 EUR | 0.041637 EVMN |
| 1 EUR | 0.083274 EVMN |
| 5 EUR | 0.41637 EVMN |
| 10 EUR | 0.83274 EVMN |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
EVMN is trading at €12.00, -0.94% over the last 24 hours. Track live moves on the price chart at the top of this page.
The EVMN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. EVMN is currently trading at €12.00, -0.94% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on EVMN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. EVMN's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from EVMN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against EVMN's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Evommune, Inc.'s market cap is currently 440.24M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume4.03K
24h highest12.2637 EUR
24h lowest12.0704 EUR
24h Price movement-0.94%
Start trade with EVMN Perpetual
Sign up to trade